Page 4 - Michael Irwig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hormone treatments may raise blood pressure in transgender people By (0) Gender-affirming hormone therapy was linked to changes in systolic blood pressure, a new study found. Photo by agilemktg1/Flickr Photo by agilemktg1/Flickr Monitoring blood pressure is important for transgender people, according to new research, which found changes in systolic blood pressure after the start of gender-affirming hormone therapy. Transgender men and transgender women have a higher burden of heart attack, stroke and related conditions, the study noted. Advertisement Gender-affirming hormone therapy isn't n...

Merck decided not to warn consumers of those potential risks in a 2011 update of the popular drug's label.

February 04, 2021 published at 6:20 AMReuters A bottle of Propecia is seen on a pharmacy shelf in New York City, US, August 8, 2019. Reuters Newly unsealed court documents and other records show that Merck & Co and US regulators knew about reports of suicidal behavior in men taking the company’s anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label. Internal records from Merck were made public in late January, when a federal magistrate in Brooklyn, New York, granted a 2019 Reuters motion to unseal 11...

12 Min Read (Reuters) - Newly unsealed court documents and other records show that Merck & Co and U.S. regulators knew about reports of suicidal behavior in men taking the company’s anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label. FILE PHOTO: A bottle of Propecia is seen on a pharmacy shelf in New York City, U.S., August 8, 2019. REUTERS/Zachary Goelman Internal records from Merck were made public in late January, when a federal magistrate in Brooklyn, New York, granted a 2019 Reuters motion to ...